Biography

Dr. Warren Marcus, Ph.D. is a biotechnology entrepreneur and immunology expert with over 20 years of experience in immunology research and business development. As a co-inventor of Anktiva (ALT-803), an FDA-approved IL-15 superagonist, he has made significant contributions to immunotherapy and oncology. Currently, Dr. Marcus leads WiNK Therapeutics, developing modified RNA-based therapies for Type 1 Diabetes. His expertise spans R&D, licensing, strategic growth, and commercialization, driven by a commitment to advancing innovative treatments and addressing unmet medical needs in precision medicine.

Courses

STEM to STARTUP: Turning Innovation into Entrepreneurship

2

By Dr. Warren Marcus P.hD

$249.00

Add to cart